Psyche Portfolio
Target Investment Criteria
- Experienced and seasoned C-Suite & Management Team
- Strategic and well funded Co-Investors
- Scalable business model
- Asset light and/or Low capital needs
- Data aggregation and analytics
- Proprietary IP, Technology, product or service
- Synergy with Phyto portfolio ecosystem
- 3-6 month due diligence monitoring
- Visible Exit strategy and Path to monitization
Our Investment Portfolio
Pioneering the intersection between psychedelic medicine and science.
Find ketamine clinics and psychedelic therapies around the globe.
A meditation and brain sensing headband that allows you to train your mind.
Designing altered states of consciousness for mental health therapeutics.
Launch or Expand Your Mental Health Clinic
Leveraging technical advances in computing to deconstruct and analyze EEGs.
Went Public 2024
NASDAQ: AIFF
See the world through a new lens with our at-home ketamine treatment for anxiety and depression